CNS Metastases
Showing 1 - 25 of 3,679
Metastatic Cancer, Brain Metastases Trial in Camden (Stereotactic Radiosurgery)
Withdrawn
- Metastatic Cancer
- Brain Metastases
- Stereotactic Radiosurgery
-
Camden, New JerseyMD Anderson Cancer Center at Cooper
Dec 21, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +2 more
- Binimetinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)
Terminated
- Malignant Melanoma
- Brain Metastases
- E6201
- E6201 plus dabrafenib
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Mar 5, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
NSCLC, EGFR Gene Mutation, Brain Metastases Trial in Worldwide (AZD3759, Erlotinib, Gefitinib)
Completed
- Non-small Cell Lung Cancer
- +2 more
- AZD3759
- +2 more
-
Hefei, Anhui, China
- +57 more
Nov 18, 2022
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)
Withdrawn
- Breast Cancer
- +3 more
- Tucatinib
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 28, 2022
Radiotherapy, Brain Metastases, Sensitivity Trial in Lund (Brain metastases radiation)
Recruiting
- Radiotherapy
- +3 more
- Brain metastases radiation
-
Lund, SwedenLund University Hospital
Jan 5, 2021
Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)
Recruiting
- Neuroblastoma
- +2 more
- 131I-omburtamab
-
Los Angeles, California
- +11 more
Dec 17, 2021
Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Recurrent Non Small Cell Lung Cancer
-
Basking Ridge, New Jersey
- +6 more
Aug 1, 2022
Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)
Completed
- Advanced Cancer
- Brain Metastases
-
New Orleans, LouisianaTulane University Medical Center
Nov 3, 2022
Brain Metastases, CNS Tumor, CNS Disorder, Intracranial Trial in Australia, United States (Stereotactic radiosurgery)
Recruiting
- Brain Metastases
- +2 more
- Stereotactic radiosurgery
-
Birmingham, Alabama
- +4 more
Jul 13, 2022
Metastatic Breast Cancer, CNS (CNS) Metastases Trial in United States (Lapatinib in Tandem With Capecitabine)
Completed
- Metastatic Breast Cancer
- Central Nervous System (CNS) Metastases
- Lapatinib in Tandem With Capecitabine
-
Ann Arbor, Michigan
- +8 more
Jan 25, 2021
HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)
Active, not recruiting
- HER2-positive Metastatic Breast Cancer
- Central Nervous System Metastases
- ATEZOLIZUMAB
- +2 more
-
Chicago, Illinois
- +1 more
Mar 14, 2022
Glioblastoma, Brain Metastases Trial in Phoenix (ceritinib 750mg)
Completed
- Glioblastoma
- Brain Metastases
- ceritinib 750mg
-
Phoenix, ArizonaBarrow Brain and Spine
Dec 10, 2020
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
NSCLC Trial in Worldwide (Entrectinib, Crizotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Barretos, SP, Brazil
- +66 more
Jan 27, 2023
Non Small Cell Lung Cancer, Brain Metastases Trial in Seoul (Dacomitinib)
Recruiting
- Non Small Cell Lung Cancer
- Brain Metastases
-
Seoul, Korea, Republic ofJong-Mu Sun
Jan 1, 2021
NSCLC Trial in Changsha (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
May 19, 2022
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 1, 2023
NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)
Completed
- Non-Small Cell Lung Cancer
- Brain Neoplasms
- bevacizumab
- +2 more
- (no location specified)
Dec 9, 2022
Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)
Recruiting
- Breast Cancer Metastatic
- Irinotecan Hydrochloride
-
Badalona, Spain
- +19 more
Jan 18, 2023
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023